Cart
sales@molnova.com
S29434
CAS No. 874484-20-5
S29434( —— )
Catalog No. M20697 CAS No. 874484-20-5
S29434 (NMDPEF) is a potent competitiveinhibitor of quinone reductase 2 (QR2;IC50:5-16nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 126 | In Stock |
|
| 5MG | 116 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameS29434
-
NoteResearch use only, not for human use.
-
Brief DescriptionS29434 (NMDPEF) is a potent competitiveinhibitor of quinone reductase 2 (QR2;IC50:5-16nM).
-
DescriptionS29434 (NMDPEF) is a potent competitiveinhibitor of quinone reductase 2 (QR2;IC50:5-16nM).
-
In VitroCell Autophagy Assay Cell Line:HepG2 cell line Concentration:5 and 10 μM Incubation Time:24 hours Result:Mitochondrial ROS-independently and QR2-dependently triggered autophagy, and dose-dependently induced LC3-II which is a marker of autophagy vesicles.
-
In VivoAnimal Model:CH3 wild-type mice Dosage:1 and 15 mg/kg Administration:Intraperitoneal injection; 1 and 15 mg/kg once Result:Positively affected memory by inhibiting QR2.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetNADPH
-
RecptorQuinone reductase 2(QR2)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number874484-20-5
-
Formula Weight374.39
-
Molecular FormulaC21H18N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:12.5 mg/mL?(33.39 mM)
-
SMILESCOc1ccc2n3Cc4cccnc4-c3c(CCNC(=O)c3ccco3)c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Boutin JA Bouillaud F Janda Eet al.S29434 a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization[J].Mol Pharmacol. 2019 Mar;95(3):269-285.
molnova catalog
related products
-
GLX351322
GLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM.
-
NQO1 substrate
NQO1 substrate is a highly potent NQO1 substrate with potential antitumor activity for leukemia research.
-
AKR1C1-IN-1
AKR1C1-IN-1 is a human 20α-hydroxysteroid dehydrogenase inhibitor (AKR1C1,Ki: 4 nM).AKR1C1-IN-1 inhibits the metabolism of progesterone that in AKR1C1-overexpressed BAECs (IC50:460 nM).
